Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-24 @ 1:00 PM
NCT ID:
NCT01540461
Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.
Inclusion Criteria:
Subjects with:
* Confirmed Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
* Not having received prior systemic treatment for advanced HCC
* Normal or moderately impaired liver function (Child-Pugh Class A or B (CP total score of ≤ 7))
* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
Exclusion Criteria:
Subjects with:
* Brain metastasis or evidence of leptomeningeal disease
* History of impaired brain function (encephalopathy) or active heart disease
* Unmanageable fluid in the abdomen (ascites)
* Bleeding esophageal or gastric varices within 2 months prior to inclusion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01540461
Study Brief:
Protocol Section:
NCT01540461